ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,107Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 973

$604K Total Retail Price of All Prescriptions

Rank: 79 out of 973

367 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 367 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 367 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,203 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 1,011 969 1 2
WARFARIN SODIUM 624 613 2 10
SIMVASTATIN 575 548 3 1
POTASSIUM CHLORIDE 514 482 4 9
AMLODIPINE BESYLATE 486 462 5 7
HYDROCODONE-ACETAMINOPHEN 362 354 S3 6 4
FUROSEMIDE 348 307 7 6
OMEPRAZOLE 318 302 8 5
HYDROCHLOROTHIAZIDE 288 264 9 11
ATENOLOL 284 282 10 16
METFORMIN HCL 261 238 11 8
LOSARTAN POTASSIUM 220 208 12 19
METOPROLOL TARTRATE 214 202 13 13
LISINOPRIL 212 200 14 3
GABAPENTIN 179 179 15 12
ATORVASTATIN CALCIUM 165 151 16 15
ALLOPURINOL 164 161 17 29
ALENDRONATE SODIUM 157 130 18 24
METOPROLOL SUCCINATE 149 144 19 17
NAMENDA 147 137 20 31
ENALAPRIL MALEATE 140 112 21 55
ZETIA 137 133 22 81
LANTUS 128 128 23 39
DONEPEZIL HCL 123 120 24 26
CARVEDILOL 110 110 25 27
FLUTICASONE PROPIONATE 109 97 26 35
LOSARTAN-HYDROCHLOROTHIAZIDE 106 101 27 46
SYNTHROID 98 98 28 50
SPIRONOLACTONE 96 83 29 49
PREMARIN 91 91 R 30 116
NOVOLOG 85 72 31 82
METHOTREXATE 79 72 32 227
LIPITOR 79 70 32 139
DILTIAZEM ER 78 72 34 109
OXYBUTYNIN CHLORIDE ER 75 75 35 125
GLYBURIDE 74 60 R 36 59
TAMSULOSIN HCL 70 57 37 28
MELOXICAM 70 70 37 23
FLUOXETINE HCL 70 58 37 56
CLOPIDOGREL 69 64 40 44
RANITIDINE HCL 68 56 41 45
AMLODIPINE BESYLATE-BENAZEPRIL 68 68 41 80
FENTANYL 65 44 S2 43 53
ALBUTEROL SULFATE 62 50 44 137
BUMETANIDE 61 61 45 103
NEXIUM 61 49 45 30
PANTOPRAZOLE SODIUM 59 59 47 37
SERTRALINE HCL 59 59 47 21
VENLAFAXINE HCL 57 57 49 192
CYMBALTA 56 43 50 40
VERAPAMIL ER 55 55 51 111
OXYBUTYNIN CHLORIDE 55 54 51 92
TRIAMTERENE-HCTZ 53 53 53 51
POLYETHYLENE GLYCOL 3350 52 43 54 36
PREDNISONE 51 51 55 33
TRIAMTERENE-HYDROCHLOROTHIAZID 50 50 56 140
PLAVIX 50 46 56 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.